Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
APRE compared with PYPD: revenue, margins and what each company keeps, and the suppliers and customers both name
APRE
Aprea Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PYPD
PolyPid Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
APRE
Aprea Therapeutics, Inc.
vs
PYPD
PolyPid Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
APRE, solid
PYPD, dashed
APRE
Aprea Therapeutics, Inc.
Change
0.50
▲
+3.30%
· post 0.50
· delayed
Mkt cap
$6.1M
Revenue
$3,337
Q4 FY25
Revenue
$285,759
FY25
PYPD
PolyPid Ltd.
Change
5.35
▼
−0.74%
· post 5.35
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$88.1M
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 2 '26
delayed
APRE
Aprea Therapeutics, Inc.
vs
PYPD
PolyPid Ltd.
0.50
▲
+3.30%
post 0.50
delayed
Price
5.35
▼
−0.74%
post 5.35
delayed
$6.1M
Mkt cap
$88.1M
Q4 FY25
$3,337
Revenue
—
FY25
$285,759
Revenue
—
Change
Change
APRE
0.50
▲
+3.30%
vs
PYPD
5.35
▼
−0.74%
After hours
Nov 2 '26
delayed